Both in Pharmaceuticals
MetaVia vs Lexaria Bioscience
Over the past year MTVA returned −88.7% and LEXX returned −75.6%; their daily moves had a correlation of 0.01.
MTVA −88.7% LEXX −75.6%Growth of $1, one year, split-adjusted
| Metric | MTVA | LEXX |
|---|---|---|
| Price | $1.34 | $4.07 |
| Market cap | $8.8M | $8.6M |
| Today | +6.35% | +0.99% |
| 1 month | −9.5% | +25.6% |
| 6 months | −4.3% | −59.8% |
| Year to date | −84.1% | −56.0% |
| 1 year | −87.8% | −73.9% |
| Revenue growth (YoY) | — | −100.0% |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | 44.2× |
| Net cash | $9.8M | $3.6M |
| Dividend yield | — | — |
| Volatility (60d) | 65.1% | 195.3% |
| Short % of float | 2.9% | 16.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).